¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.
µ¿¹°¿ë »óó ¼¼Á¤Á¦ ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :
¼¼°è µ¿¹°¿ë »óó ¼¼Á¦ ½ÃÀå ±Ô¸ð´Â 2030³â¿¡´Â 3¾ï 2,381¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í, 2025³âºÎÅÍ 2030³â±îÁö CAGR 7.23%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ½ÃÀå¿¡´Â µ¿¹° »óóÀÇ È¿°úÀûÀÎ ¼¼Ã´, °ü¸® ¹× Ä¡À¯¸¦ ÃËÁøÇϱâ À§ÇØ °í¾ÈµÈ ´Ù¾çÇÑ Á¦Ç°°ú ¼ºñ½º°¡ Æ÷ÇԵ˴ϴÙ.
¼öÀÇÇаú ±â¼úÀÇ ¹ßÀüÀº Çõ½ÅÀûÀ̰í È¿°úÀûÀÎ »óó ¼¼Á¤Á¦ÀÇ Ã³¹æÀ» °³¹ßÇÏ¿© ¾ÈÀü¼º°ú È¿À²¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù. ½ÃÀå È®´ë´Â µ¿¹° »óÇØÀÇ À¯º´·ü Áõ°¡¿Í ¼öÀÇ»ç ¼ºñ½º ¹üÀ§ È®´ë·Î ´õ¿í ÃËÁøµÇ°í ÀÖ½À´Ï´Ù.
Á¦¾à±â¾÷°ú ¼öÀÇ»ç Àü¹®°¡¿ÍÀÇ Àü·«Àû Çù·Â°ü°è¿Í µ¿¹°¿ë ÀǾàǰÀÇ À¯Åë¿¡ µðÁöÅÐ Ç÷§ÆûÀÌ ³Î¸® ä¿ëµÇ°í ÀÖ´Â °Íµµ ½ÃÀåÀÇ »ó½Â ±Ëµµ¸¦ ÁöÁöÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 8¿ù, Elanco Animal Health Incorporated´Â ÄÝ·Î¶óµµ ÁÖ¸³ ´ëÇÐÀÇ AgNext¿Í Àü·«Àû Á¦ÈÞ¸¦ ¸Î¾î Ãà»ê¾÷¿¡¼ Áö¼Ó°¡´É¼º ³ë·ÂÀ» ÃßÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ Á¦ÈÞ´Â Ãà»ê ½Çõ¿¡¼ Áö¼Ó°¡´É¼ºÀ» °ÈÇÒ ¼ö ÀÖ´Â ±âȸ¸¦ Ȱ¿ëÇϴµ¥ ÀÖ¾î¼ ¸Å¿ì Áß¿äÇÑ Áøº¸ÀÔ´Ï´Ù.
µ¿¹°¿ë »óó ¼¼Á¤Á¦ ½ÃÀå : ºÐ¼® °³¿ä
- µ¿¹°º°·Î´Â ¹Ý·Áµ¿¹° ºÎ¹®ÀÌ ½ÃÀåÀ» µ¶Á¡Çϰí, 2024³â¿¡´Â 59.06%ÀÇ Å« ¼öÀÍ Á¡À¯À²À» ȹµæÇß½À´Ï´Ù. È¿°úÀûÀÎ »óó ÄÉ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä´Â ¼öÀÇÇÐ ¼ö¼ú°ú ¸¸¼º Áúȯ °ü¸®ÀÇ Ã¤¿ë¿¡ µû¶ó Áõ°¡Çϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ¹Ý·Áµ¿¹°Àº Á¤½ÅÀûÀÎ Çູ°¨À» ÇöÀúÇÏ°Ô Çâ»ó½Ã۰í ÁÖÀÎÀÇ 74.0%°¡ Á¤½ÅÀûÀÎ °Ç° ÁõÁø È¿°ú¸¦ ÁöÀûÇϰí ÀÖ½À´Ï´Ù.
- ÀüÅëÀûÀÎ ¼¼Á¦ ºÎ¹®Àº 2024³â 60.83%ÀÇ ÃÖ´ë ¼öÀÍ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. µ¿¹° »óÇØÀÇ ¹ß»ýÀÌ Áõ°¡ÇÏ°í ¿¹¹æ °Ç° °ü¸®¿¡ ´ëÇÑ ÁÖ¸ñÀÌ ³ô¾ÆÁö¸é¼ ±âÁ¸ÀÇ »óó ¼¼Á¦¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.
- ÃÖÁ¾ ¿ëµµº°·Î´Â µ¿¹°º´¿ø ¹× Áø·á¼Ò ºÐ¾ß°¡ 2024³â¿¡ 66.70%ÀÇ ÃÖ´ë ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. µ¿¹° º¹Áö¿¡ ´ëÇÑ »çȸÀÇ ÀǽÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¹Ý·Áµ¿¹° ÁÖÀÎÀº ¹Ý·Áµ¿¹°ÀÌ ºÎ»óÀ» ÀÔÀ» ¶§ Àü¹®°¡ÀÇ µµ¿òÀ» ¿ä±¸ÇÏ´Â °æÇâÀÌ °ÇØÁö°í ÀÖ½À´Ï´Ù. ÀÌ Ãß¼¼´Â µ¿¹° º´¿ø ¹× Áø·á¼Ò·ÎÀÇ ¹æ¹®À» Áõ°¡½Ã۰í Ä¡·á °úÁ¤¿¡¼ »óó ¼¼Á¤Á¦¸¦ ³Î¸® »ç¿ëÇÕ´Ï´Ù.
¸ñÂ÷
Á¦1Àå ºÐ¼® ¹æ¹ý¡¤¹üÀ§
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå µ¿¹°¿ë »óó ¼¼Á¤Á¦ ½ÃÀå : º¯µ¿ ¿äÀΡ¤°æÇ⡤¹üÀ§
- ½ÃÀå ¿¬°ü Àü¸Á
- »óÀ§ ½ÃÀå Àü¸Á
- °ü·Ã/ºÎ¼ö½ÃÀå Àü¸Á
- ½ÃÀå ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
- µ¿¹°¿ë »óó ¼¼Á¤Á¦ ½ÃÀå : ºÐ¼® µµ±¸
- ¾÷°è ºÐ¼® : Porter's Five Forces ºÐ¼®
- PESTEL ºÐ¼®
Á¦4Àå µ¿¹°¿ë »óó ¼¼Á¤Á¦ ½ÃÀå : µ¿¹°º° ÃßÁ¤¡¤µ¿Ç⠺м®
- ¼¼°èÀÇ µ¿¹°¿ë »óó ¼¼Á¤Á¦ ½ÃÀå : ´ë½Ãº¸µå, µ¿¹°º°
- ¼¼°èÀÇ µ¿¹°¿ë »óó ¼¼Á¤Á¦ ½ÃÀå :º¯µ¿ ºÐ¼®, µ¿¹°º°
- ¼¼°èÀÇ µ¿¹°¿ë »óó ¼¼Á¤Á¦ ½ÃÀå : µ¿¹°º°(¼öÀÍ º£À̽º)
- ¹Ý·Áµ¿¹°
- °¡Ãà
Á¦5Àå µ¿¹°¿ë »óó ¼¼Á¤Á¦ ½ÃÀå : Á¦Ç°º° ÃßÁ¤¡¤µ¿Ç⠺м®
- ¼¼°èÀÇ µ¿¹°¿ë »óó ¼¼Á¤Á¦ ½ÃÀå : ´ë½Ãº¸µå, Á¦Ç°º°
- ¼¼°èÀÇ µ¿¹°¿ë »óó ¼¼Á¤Á¦ ½ÃÀå : º¯µ¿ ºÐ¼®, Á¦Ç°º°
- Á¦Ç°º°(¼öÀÍ ±âÁØ)
- ±âÁ¸ ¼¼Á¤Á¦
- °íµµ ¼¼Á¤Á¦
Á¦6Àå µ¿¹°¿ë »óó ¼¼Á¤Á¦ ½ÃÀå : ÃÖÁ¾ ¿ëµµº° ÃßÁ¤¡¤µ¿Ç⠺м®
- ¼¼°èÀÇ µ¿¹°¿ë »óó ¼¼Á¤Á¦ ½ÃÀå : ´ë½Ãº¸µå, ÃÖÁ¾ ¿ëµµº°
- ¼¼°èÀÇ µ¿¹°¿ë »óó ¼¼Á¤Á¦ ½ÃÀå : º¯µ¿ ºÐ¼®, ÃÖÁ¾ ¿ëµµº°
- ÃÖÁ¾ ¿ëµµº°(¼öÀÍ ±âÁØ)
- µ¿¹° º´¿ø ¹× Áø·á¼Ò
- ÀçÅÃÄ¡·á
- ¿¬±¸±â°ü
Á¦7Àå µ¿¹°¿ë »óó ¼¼Á¤Á¦ ½ÃÀå : Áö¿ªº° ÃßÁ¤¡¤µ¿Ç⠺м®(µ¿¹°º°, Á¦Ç°º°, ÃÖÁ¾ ¿ëµµº°)
- Áö¿ªº° ´ë½Ãº¸µå
- ½ÃÀå ±Ô¸ð ¿¹Ãø°ú µ¿Ç⠺м®(2018-2030³â)
- ºÏ¹Ì
- À¯·´
- ¿µ±¹
- µ¶ÀÏ
- ÇÁ¶û½º
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- ½º¿þµ§
- µ§¸¶Å©
- ³ë¸£¿þÀÌ
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áß±¹
- ÀϺ»
- Àεµ
- Çѱ¹
- È£ÁÖ
- ű¹
- ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ³²¾ÆÇÁ¸®Ä«
- ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
- Äí¿þÀÌÆ®
Á¦8Àå °æÀï ±¸µµ
- ±â¾÷/°æÀïÀÇ ºÐ·ù
- º¥´õ »óȲ
- ÁÖ¿ä À¯Åë¾÷ü¡¤Ã¤³Î ÆÄÆ®³Ê ¸ñ·Ï
- ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
- Elanco
- Vetoquinol
- Virbac
- Innovacyn, Inc.
- Axio Biosolutions Pvt Ltd
- Jorgen Kruuse
- Dechra Pharmaceuticals
- Neogen Corporation
- B Braun Melsungen
- Pet Natural Remedies
- Zoetis
JHS 25.03.04
Veterinary Wound Cleansers Market Growth & Trends:
The global Veterinary Wound Cleansers market size is expected to reach USD 323.81 million in 2030 and is projected to grow at a CAGR of 7.23% from 2025 to 2030. The market includes a variety of products and services designed to promote the effective cleaning, management, and healing of wounds in animals.
Advancements in veterinary science and technology have led to the development of innovative and more effective wound cleanser formulations, enhancing safety and efficacy. The market expansion is further propelled by the growing prevalence of animal injuries and the expanding scope of veterinary services.
Strategic collaborations between pharmaceutical companies and veterinary professionals and the widespread adoption of digital platforms for distributing veterinary products support the market's upward trajectory. For instance, in August 2022, Elanco Animal Health Incorporated entered a strategic alliance with AgNext at Colorado State University to promote sustainability initiatives within animal agriculture. This collaboration represents a pivotal advancement in harnessing opportunities to enhance sustainability in livestock practices.
Veterinary Wound Cleansers Market Report Highlights:
- Based on Animal, The companion animal segment dominated the market, capturing a significant revenue share of 59.06% in 2024, as pet owners prioritize their pets' health. The demand for effective wound care solutions is increasing due to adoption of more veterinary surgeries and chronic condition management. In addition, pets significantly improve mental well-being, with 74.0% of owners noting enhanced mental health benefits
- The traditional cleansers segment held the largest revenue share of 60.83% in 2024. The rising occurrence of animal injuries and an increasing focus on preventive healthcare resulted in a greater demand for conventional wound-cleaning products
- Based on end use, the veterinary hospitals and clinics segment dominated the market with the largest revenue share of 66.70% in 2024. As public awareness regarding animal welfare grows, pet owners are more inclined to seek professional help when their pets sustain injuries. This trend led to increased visits to veterinary clinics and hospitals where wound-cleansing products are utilized extensively during treatment processes
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Animal
- 1.2.2. Product
- 1.2.3. End Use
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for primary interviews in North America
- 1.4.5.2. Data for primary interviews in Europe
- 1.4.5.3. Data for primary interviews in Asia Pacific
- 1.4.5.4. Data for primary interviews in Latin America
- 1.4.5.5. Data for Primary interviews in MEA
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Animal Outlook
- 2.2.2. Product Outlook
- 2.2.3. End Use Outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Veterinary Wound Cleansers Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Increasing Incidence of Animal Injuries and Surgeries
- 3.2.1.2. Advancements in Veterinary Wound Management Technology
- 3.2.1.3. Growing Awareness of Veterinary Wound Management
- 3.2.2. Market restraint analysis
- 3.2.2.1. Lack of Awareness and Accessibility in Rural Areas
- 3.3. Veterinary Wound Cleansers Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
Chapter 4. Veterinary Wound Cleansers Market: Animal Estimates & Trend Analysis
- 4.1. Global Veterinary Wound Cleansers Market: Animal Dashboard
- 4.2. Global Veterinary Wound Cleansers Market: Animal Movement Analysis
- 4.3. Global Veterinary Wound Cleansers Market by Animal, Revenue
- 4.4. Companion Animal
- 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5. Livestock Animal
- 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Veterinary Wound Cleansers Market: Product Estimates & Trend Analysis
- 5.1. Global Veterinary Wound Cleansers Market: Product Dashboard
- 5.2. Global Veterinary Wound Cleansers Market: Product Movement Analysis
- 5.3. Global Veterinary Wound Cleansers Market Estimates and Forecasts, by Product, Revenue (USD Million)
- 5.4. Traditional Cleansers
- 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5. Advanced Cleansers
- 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Veterinary Wound Cleansers Market: End Use Estimates & Trend Analysis
- 6.1. Global Veterinary Wound Cleansers Market: End Use Dashboard
- 6.2. Global Veterinary Wound Cleansers Market: End Use Movement Analysis
- 6.3. Global Veterinary Wound Cleansers Market Estimates and Forecasts, By End Use, Revenue (USD Million)
- 6.4. Veterinary Hospitals & Clinics
- 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5. Homecare
- 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6. Research Institutes
- 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Veterinary Wound Cleansers Market: Regional Estimates & Trend Analysis by Animal, Product, and End Use
- 7.1. Regional Dashboard
- 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 7.3. North America
- 7.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Key Country Dynamics
- 7.3.2.2. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.3. Canada
- 7.3.3.1. Key Country Dynamics
- 7.3.3.2. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.4. Mexico
- 7.3.4.1. Key Country Dynamics
- 7.3.4.2. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4. Europe
- 7.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.2. U.K.
- 7.4.2.1. Key Country Dynamics
- 7.4.2.2. U.K. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.3. Germany
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.4. France
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.5. Italy
- 7.4.5.1. Key Country Dynamics
- 7.4.5.2. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.6. Spain
- 7.4.6.1. Key Country Dynamics
- 7.4.6.2. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.7. Sweden
- 7.4.7.1. Key Country Dynamics
- 7.4.7.2. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.8. Denmark
- 7.4.8.1. Key Country Dynamics
- 7.4.8.2. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.9. Norway
- 7.4.9.1. Key Country Dynamics
- 7.4.9.2. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5. Asia Pacific
- 7.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.2. China
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Japan
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.4. India
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.5. South Korea
- 7.5.5.1. Key Country Dynamics
- 7.5.5.2. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.6. Australia
- 7.5.6.1. Key Country Dynamics
- 7.5.6.2. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.7. Thailand
- 7.5.7.1. Key Country Dynamics
- 7.5.7.2. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6. Latin America
- 7.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.2. Brazil
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. Argentina
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7. Middle East and Africa
- 7.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.7.2. Saudi Arabia
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.3. South Africa
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.4. UAE
- 7.7.4.1. Key Country Dynamics
- 7.7.4.2. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.5. Kuwait
- 7.7.5.1. Key Country Dynamics
- 7.7.5.2. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Company/Competition Categorization
- 8.2. Vendor Landscape
- 8.2.1. List of key distributors and channel partners
- 8.2.2. Key company market share analysis, 2023
- 8.2.3. Elanco
- 8.2.3.1. Company overview
- 8.2.3.2. Financial performance
- 8.2.3.3. Product benchmarking
- 8.2.3.4. Strategic initiatives
- 8.2.4. Vetoquinol
- 8.2.4.1. Company overview
- 8.2.4.2. Financial performance
- 8.2.4.3. Product benchmarking
- 8.2.4.4. Strategic initiatives
- 8.2.5. Virbac
- 8.2.5.1. Company overview
- 8.2.5.2. Financial performance
- 8.2.5.3. Product benchmarking
- 8.2.5.4. Strategic initiatives
- 8.2.6. Innovacyn, Inc.
- 8.2.6.1. Company overview
- 8.2.6.2. Financial performance
- 8.2.6.3. Product benchmarking
- 8.2.6.4. Strategic initiatives
- 8.2.7. Axio Biosolutions Pvt Ltd
- 8.2.7.1. Company overview
- 8.2.7.2. Financial performance
- 8.2.7.3. Product benchmarking
- 8.2.7.4. Strategic initiatives
- 8.2.8. Jorgen Kruuse
- 8.2.8.1. Company overview
- 8.2.8.2. Financial performance
- 8.2.8.3. Product benchmarking
- 8.2.8.4. Strategic initiatives
- 8.2.9. Dechra Pharmaceuticals
- 8.2.9.1. Company overview
- 8.2.9.2. Financial performance
- 8.2.9.3. Product benchmarking
- 8.2.9.4. Strategic initiatives
- 8.2.10. Neogen Corporation
- 8.2.10.1. Company overview
- 8.2.10.2. Financial performance
- 8.2.10.3. Product benchmarking
- 8.2.10.4. Strategic initiatives
- 8.2.11. B Braun Melsungen
- 8.2.11.1. Company overview
- 8.2.11.2. Financial performance
- 8.2.11.3. Product benchmarking
- 8.2.11.4. Strategic initiatives
- 8.2.12. Pet Natural Remedies
- 8.2.12.1. Company overview
- 8.2.12.2. Financial performance
- 8.2.12.3. Product benchmarking
- 8.2.12.4. Strategic initiatives
- 8.2.13. Zoetis
- 8.2.13.1. Company overview
- 8.2.13.2. Financial performance
- 8.2.13.3. Product benchmarking
- 8.2.13.4. Strategic initiatives